Sanofi is following in the footsteps of ... said the pharma group. The range of consumer healthcare products it offers will also be “streamlined” ahead of the spin-off. According to the ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for ... a good fit with its existing business in terms of products and geographies, giving it much increased ...

Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited has announced the ...

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.

Subject to shareholder approval at the subsequent Annual General Meeting (AGM), the Board of Directors of Sanofi Consumer ...

Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

Sanofi Consumer Healthcare India Limited informed the exchanges that it has approved a final dividend of ₹55 per equity share having a face value of ₹10 each for the financial year ending ...

Sanofi Consumer Heal - Determination Of Book Closure And Record Dates For Dividend Further to our letter dated 20th February, 2025 wherein the Board recommended a final dividend of Rs. 55 per ...

Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit ...